‹

10. The Distributed Self

EN

10. The Distributed Self

A phrase circulates in popular writing: most of the body's serotonin lives in the gut, not the brain. The number attached to it is real. Somewhere between ninety and ninety-five percent of the serotonin in a human body sits in the digestive tract, made and stored by enterochromaffin cells — hormone-releasing cells scattered through the lining of the intestine, so named because a particular stain turns them yellow-brown ("chromaffin") under a microscope. Most of what circulates beyond the gut wall gets mopped up and stored by platelets, the blood cells that help wounds clot, using a transport protein called SERT that pulls serotonin out of the bloodstream and locks it inside.

What that ninety-to-ninety-five percent figure does not mean is that the gut is quietly running the emotional weather of the brain. Serotonin does not cross the blood-brain barrier, the tightly sealed layer of cells that filters what reaches brain tissue from the blood. The gut's serotonin governs gut business: the squeezing motion that moves food along (motility), the release of digestive secretions, and the sensing of nutrients as they pass through. The brain manufactures its own separate supply, synthesized locally, operating in a compartment the gut's pool never touches. A 2023 Psychology Today piece on gut-serotonin physiology makes this distinction explicit, pushing back directly against the popular leap from "most of your serotonin is in your gut" to "your gut controls your mood." The physiology is compartmentalized. The inference is not licensed by the physiology.

This matters for a specific reason: the fact is often deployed as if it settles something about mood, when what it actually settles is something about anatomy. Two separate serotonin systems exist in one body, made from the same starting molecule but manufactured, stored, and used in different places for different jobs. The mistake is treating "same molecule" as "same system." It is not.

The nerve that mostly listens

The vagus nerve is the longest cranial nerve in the body, running from the brainstem down through the neck and chest into the abdomen, touching the heart, lungs, and gut along the way. Its name comes from the Latin for "wandering," which is roughly what it does anatomically. What is less commonly known is its direction of traffic. Roughly eighty percent of vagus nerve fibers are afferent — carrying signals from the body up to the brain — and only about twenty percent are efferent, carrying commands from the brain back down to the body. The nerve is built, overwhelmingly, to listen.

Those afferent signals arrive first at a brainstem structure called the nucleus tractus solitarii, then get relayed onward to the thalamus, hippocampus, amygdala, and insula — a set of brain regions involved in relaying sensory information, forming memories, generating fear and threat responses, and building a felt sense of the body's internal state. This last function has a name: interoception, the sensing of internal bodily conditions — heart rate, gut tension, breath — the same basic sense that tells a person they are hungry or that their heart is pounding, except operating continuously and mostly below conscious notice.

In animal studies, disrupting vagal afferent feedback impairs normal emotional regulation. In humans, the evidence linking pathological disruption of these afferent pathways to mood-disorder risk is real but is explicitly described in the reviewing literature as accumulating and preliminary, not settled. Vagus nerve stimulation — an implanted or external device that electrically stimulates the nerve — shows some promise as an add-on treatment for depression that has not responded to standard treatment, but that clinical result does not, by itself, prove the mechanism. A treatment can work through a pathway science has not yet fully mapped. Two reviews, one published in 2020 and a companion in Biological Psychiatry in 2025, lay out the anatomy with confidence and the causal story with appropriate hedging. The eighty percent figure is solid. What it explains about human despair is still being worked out.

The plain-English version: the body spends far more of this nerve's bandwidth telling the brain how it feels than the brain spends telling the body what to do. Emotional states, on this architecture, are not purely a top-down brain product broadcast outward. They are built, in part, from information flowing upward — a felt sense of gut, heart, and breath that arrives in emotion-processing regions of the brain continuously, whether or not it is ever consciously noticed.

A second widely repeated claim about the biology of connection has not held up nearly as well, and it is worth telling honestly because the correction is itself informative about how this kind of science gets overclaimed.

Oxytocin acquired a public nickname — the "trust hormone," sometimes the "love hormone" — largely on the strength of a 2005 study using something called the Envelope Task, in which participants who inhaled oxytocin nasally showed a large jump in trusting behavior toward a stranger compared to a placebo group. The finding was dramatic, easy to summarize, and spread widely. It has not survived direct replication. In 2015, two independently powered replication attempts of the original Envelope Task effect were both published as non-significant — meaning neither found the trust boost the original study reported, even with study designs built specifically to detect it if it were there. A subsequent meta-analysis pooling replication attempts found the combined effect of intranasal oxytocin on trust to be small and not reliably different from zero.

This is not fringe skepticism aimed at the field from outside. The researchers who ran and published these replications work inside oxytocin science; this is the field correcting itself, which is exactly what a healthy science is supposed to do when an early, small, exciting result turns out not to generalize. The honest current position is that "oxytocin is the bonding and trust hormone" is a contested oversimplification, not an established fact — the original large effect either does not exist or is small enough that early small-sample studies were never positioned to detect it reliably. A pop-science claim repeated widely enough starts to sound settled. This one was not, and the correction is on the public record.

Isolation, measured

Away from single hormones and single nerves, a broader and much better replicated finding concerns the physiological cost of disconnection itself. In 2015, Julianne Holt-Lunstad and colleagues published a meta-analysis in Perspectives on Psychological Science pooling data from a literature search spanning January 1980 to February 2014, drawing on more than 3.4 million participants across confound-controlled studies. They calculated weighted average odds ratios for all-cause mortality associated with three related but distinct states: social isolation (an odds ratio of 1.29, a 29 percent increase in mortality likelihood), loneliness (1.26, a 26 percent increase), and living alone (1.32, a 32 percent increase). These effects held up consistently across gender, length of follow-up, and world region. Notably, objective measures of isolation and subjective feelings of loneliness did not differ significantly in their predictive strength — the felt experience of being alone tracked mortality risk about as well as the measurable fact of having few social contacts. The effects were larger in people younger than sixty-five. This is not a disputed finding; later work, including a 2023 meta-analysis of loneliness and mortality in older adults, reaches the same directional conclusion. What remains genuinely open is mechanism — how, exactly, isolation gets under the skin.

One answer, partial and still being tested, comes from John Cacioppo at the University of Chicago and his collaborators. In a set of studies — one with 89 undergraduates, a second with 25 older adults — they measured autonomic nervous system activity, salivary cortisol (a hormone that rises under stress), sleep quality, and health behaviors, and looked for what tracked with loneliness. Two candidate mechanisms stood out as the most robust: cardiovascular activation and disrupted sleep, functioning as what the researchers called "predisease" pathways — early physiological wear that could plausibly compound into illness over time. Separately, University of Chicago reporting on this body of work states that perceived social isolation can raise the risk of premature death in older adults by fourteen percent. What the cross-sectional design of these particular studies cannot settle is direction of causation: whether loneliness produces the cardiovascular and sleep disruption, or whether people who already carry those physiological and behavioral traits are also more likely to become lonely in the first place. That question remains open in the literature, not resolved by these studies alone.

Put together, these threads describe something specific about where feeling actually happens. Not only in cortical tissue processing images and language, but in a gut manufacturing its own separate serotonin supply for its own separate purposes; in a nerve built mostly to carry the body's condition upward rather than to carry orders downward; in cardiovascular and sleep systems that measurably shift under the physiological weight of disconnection. A single hormone marketed as the biology of trust turned out to be a much smaller, much less certain effect than its nickname implied. The self that feels is not seated in one place issuing instructions outward. It is assembled, continuously, from signals arriving from many places at once — most of them never reaching conscious awareness, all of them, on the current evidence, real.

Overturned if: a large, adequately powered replication established that vagal afferent disruption or gut-brain serotonin signaling directly and reliably drives clinical mood states in humans — moving the current "accumulating, preliminary" evidence to settled causal status — while the physiological compartmentalization of serotonin (its failure to cross the blood-brain barrier) turned out to be wrong.

Sources

บทถัดไป · 11 / 1211. The Uncharted Territory
Size
Page
Font

The Architecture of Affect

❦
101. The Myth of the Broken Thermostat202. The Currency of Pursuit303. The Cost of Chronic Vigilance404. The Architecture of Resilience505. Rapid Restoration606. Relaxing the Predictive Constraint707. The Mathematics of Disappointment808. The Logic of Giving Up909. Environmental Recalibration1010. The Distributed Self1111. The Uncharted Territory1212. Agency in a Predictive World
‹ Prev10 / 12Next ›